These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33740002)

  • 1. Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Raeisi T; Rezaie H; Darand M; Taheri A; Garousi N; Razi B; Roever L; Mohseni R; Hussien Mohammed S; Alizadeh S
    PLoS One; 2021; 16(3):e0246200. PubMed ID: 33740002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
    Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
    Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
    Chen MJ; Yang WS; Chen HF; Kuo JJ; Ho HN; Yang YS; Chen SU
    Hum Reprod; 2010 Mar; 25(3):779-85. PubMed ID: 20093255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis.
    Lin K; Sun X; Wang X; Wang H; Chen X
    Front Endocrinol (Lausanne); 2020; 11():537809. PubMed ID: 33488512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
    Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R
    Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
    Chen MJ; Han DS; Yang JH; Yang YS; Ho HN; Yang WS
    Hum Reprod; 2012 Aug; 27(8):2476-83. PubMed ID: 22693174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications.
    Wang Y; Xie X; Zhu W
    J Huazhong Univ Sci Technolog Med Sci; 2010 Oct; 30(5):638-42. PubMed ID: 21063848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: A PRISMA-compliant systematic review and meta-analysis.
    Li L; Yu J; Zhou Z
    Medicine (Baltimore); 2022 Sep; 101(38):e30579. PubMed ID: 36197242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances.
    Olszanecka-Glinianowicz M; Madej P; Nylec M; Owczarek A; Szanecki W; Skałba P; Chudek J
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):238-42. PubMed ID: 23199261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines.
    Behboudi-Gandevani S; Ramezani Tehrani F; Bidhendi Yarandi R; Noroozzadeh M; Hedayati M; Azizi F
    J Endocrinol Invest; 2017 Aug; 40(8):859-866. PubMed ID: 28332170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.
    Seow KM; Juan CC; Ho LT; Hsu YP; Lin YH; Huang LW; Hwang JL
    Hum Reprod; 2007 Apr; 22(4):1100-6. PubMed ID: 17208941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.
    Toulis KA; Goulis DG; Farmakiotis D; Georgopoulos NA; Katsikis I; Tarlatzis BC; Papadimas I; Panidis D
    Hum Reprod Update; 2009; 15(3):297-307. PubMed ID: 19261627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum resistin and adiponectin levels in women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Demirci H; Oztürk C; Kan E; Ayvaz G; Arslan M
    Gynecol Endocrinol; 2009 Apr; 25(4):246-52. PubMed ID: 19408174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis.
    Tang YL; Yu J; Zeng ZG; Liu Y; Liu JY; Xu JX
    Gynecol Endocrinol; 2017 Mar; 33(3):244-249. PubMed ID: 27908216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome.
    Farshchian F; Ramezani Tehrani F; Amirrasouli H; Rahimi Pour H; Hedayati M; Kazerouni F; Soltani A
    Int J Endocrinol Metab; 2014 Jul; 12(3):e15503. PubMed ID: 25237319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.
    Teede H; Ng S; Hedger M; Moran L
    Metabolism; 2013 Oct; 62(10):1394-400. PubMed ID: 23768911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.
    Chen MJ; Chen HF; Chen SU; Ho HN; Yang YS; Yang WS
    Fertil Steril; 2009 Dec; 92(6):2041-4. PubMed ID: 19591997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome.
    Obirikorang C; Owiredu WKBA; Adu-Afram S; Acheampong E; Asamoah EA; Antwi-Boasiakoh EK; Owiredu EW
    BMC Res Notes; 2019 Aug; 12(1):513. PubMed ID: 31416473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.